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Gene organization and evolutionary history
Cullins,  containing  an  evolutionarily  conserved  cullin 
homology  domain,  are  a  family  of  structurally  related 
proteins  required  for  ubiquitin-dependent  protein 
degradation (Box 1). Two groups have made important 
contributions  to  the  discovery  of  this  protein  family. 
Kipreos et al. [1] identified cullins as a novel gene family 
involved in cell cycle regulation in nematodes. Indepen-
dently,  Mathias  et  al.  [2]  isolated  Cdc53  (cell  division 
control protein 53), a cullin homolog in budding yeast, 
and elucidated its role in ubiquitin-dependent proteolysis 
of  cell-cycle  regulators.  Thus,  cullins  are  named  after 
their role in ‘culling’, sorting or ‘selecting’ cellular proteins 
for ubiquitin-mediated proteasomal degradation (E Kipreos, 
personal communication).
The  cullin  gene  family  is  evolutionarily  conserved. 
Table 1 presents a list of the cullin family genes from a 
range of representative species with respect to their gene 
organization and expression. There are seven cullins in 
mammals (CUL1 to CUL3, CUL4a, CUL4b, CUL5, CUL7 
and  the  closely  related  p53-associated  parkin-like 
cytoplasmic  protein  (Parc)  in  Homo  sapiens,  Mus 
musculus and Rattus norvegicus), six in C. elegans (cul-1 
to cul-6) and five in Drosophila (CUL1 to CUL5). Arabi­
dopsis has five cullins (CUL1, CUL2, CUL3A, CUL4 and 
CUL5), and yeast genomes encode three cullin proteins 
(cul1, cul3, cul8 in Saccharomyces cerevisiae; cul1, cul3 
and  cul4  in  Schizosaccharomyces  pombe).  In  total,  490 
cullin  domains  in  490  proteins  are  described  in  the 
SMART nrdb database [3], which estimates 60% conser-
vation in the cullin homology domains.
Figure  1  summarizes  the  phylogenetic  relationships 
among  the  cullins  based  on  sequence  alignment.  The 
presence  of  the  Cul1  to  Cul5  genes  in  the  early-
branching  metazoans  Trichoplax  adhaerens  and 
Nematostella  vectensis  indicates  that  cullin  genes  are 
ancient  and  originated  before  the  separation  of  the 
different  animal  lineages.  An  extensive  genome-wide 
analysis  of  the  cullin  family  has  suggested  that  three 
ancestral cullin genes, termed ‘Culα’, ‘Culβ’ and ‘Culγ’, 
appeared in early eukaryotic evolution, from which the 
cullin genes evolved after the split of the unikonts (which 
include  animals  and  fungi)  and  the  bikonts  (which 
include plants). In this model, the human CUL1, CUL2, 
CUL5, CUL7 and PARC genes were derived from one 
common ancestral gene (Culα), whereas the Cul3 and 
Cul4a/4b genes evolved from two distinct ancestors, the 
Culβ and Culγ gene, respectively [4]. Notably, Cul7 and 
Parc,  found  only  in  chordates,  are  highly  similar  in 
Summary
Cullin proteins are molecular scaffolds that have 
crucial roles in the post-translational modification of 
cellular proteins involving ubiquitin. The mammalian 
cullin protein family comprises eight members (CUL1 
to CUL7 and PARC), which are characterized by a 
cullin homology domain. CUL1 to CUL7 assemble 
multi-subunit Cullin-RING E3 ubiquitin ligase (CRL) 
complexes, the largest family of E3 ligases with more 
than 200 members. Although CUL7 and PARC are 
present only in chordates, other members of the cullin 
protein family are found in Drosophila melanogaster, 
Caenorhabditis elegans, Arabidopsis thaliana and yeast. 
A cullin protein tethers both a substrate-targeting 
unit, often through an adaptor protein, and the RING 
finger component in a CRL. The cullin-organized CRL 
thus positions a substrate close to the RING-bound 
E2 ubiquitin-conjugating enzyme, which catalyzes 
the transfer of ubiquitin to the substrate. In addition, 
conjugation of cullins with the ubiquitin-like molecule 
Nedd8 modulates activation of the corresponding 
CRL complex, probably through conformational 
regulation of the interactions between cullin’s carboxy-
terminal tail and CRL’s RING subunit. Genetic studies 
in several model organisms have helped to unravel a 
multitude of physiological functions associated with 
cullin proteins and their respective CRLs. CRLs target 
numerous substrates and thus have an impact on a 
range of biological processes, including cell growth, 
development, signal transduction, transcriptional 
control, genomic integrity and tumor suppression. 
Moreover, mutations in CUL7 and CUL4B genes have 
been linked to hereditary human diseases.
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© 2011 BioMed Central Ltdsequence and both contain a CPH (conserved in CUL7, 
PARC and HERC2) domain and a DOC domain (similar 
to  the  DOC1  of  the  anaphase-promoting  complex/
cyclosome) of unknown functions (Figure 2). In human 
and  mouse,  Cul7  and  Parc  are  located  on  the  same 
chromosome in close proximity (260 kb apart). Based on 
these  findings,  Marin  et  al.  [5]  suggested  that  Parc 
originated from a gene fusion of a duplicate of Cul7 and 
an ariadne gene, which encodes a putative E3 ubiquitin 
ligase sharing structural similarity with Parkin. Fungal 
species contain only three cullin genes: Cdc53, Cul3 and 
Cul8 (also known as RTT101) in S. cerevisiae and Cul1, 
Cul3 and Cul4 in S. pombe [4]. However, Cul8/RTT101 
in Saccharomycotina differs significantly from the Cul4-
like  genes  of  other  fungi  (such  as  ascomycetes  and 
basidiomycetes) [4]. It was postulated that Cul8/RTT101 
originated  from  the  Cul4  gene  that  underwent  an 
accelerated evolution, or that Saccharo  mycotina has lost 
their Cul4-like gene and the Cul8/RTT101 gene arose in 
parallel as a result of gene duplication.
Characteristic structural features
RING  (really  interesting  new  gene)-type  E3  ubiquitin 
ligases  orchestrate  ubiquitination  by  simultaneously 
bind  ing  to  a  protein  substrate  and  anchoring  an  E2 
ubiquitin-conjugating enzyme through the RING domain 
(for detailed description of the actions of E2 and E3 in 
ubiquitination, see Boxes 1 and 2 and Figure 3). Cullins 
are molecular scaffolds that organize the largest class of 
RING  E3  ligases,  known  as  the  cullin-RING  ligase 
complexes  (CRLs).  Below  we  discuss  how  cullins  use 
their  unique  structural  properties  to  assemble  their 
cognate CRLs.
The structural properties of cullins have been revealed 
in  the  context  of  CRLs  by  high-resolution  structural 
studies  and  biochemical  reconstitution  experiments 
(Table 2). Although all the cullin (and CRL) structures 
that  have  been  solved  so  far  have  been  mammalian 
proteins (Table 2), the interactions between cullins and 
their  CRL  components  have  been  analyzed  using  bio-
chemi  cal assays in systems from yeast to humans, high-
lighting  an  extraordinary  conservation  regarding  the 
scaffolding functions of cullins. Thus, the cullin and CRL 
structural models discussed in this section are generally 
applicable to counterparts of all origins.
CUL1 to CUL5 have a long stalk-like amino-terminal 
domain (NTD), consisting of three cullin repeats (CR1 
to CR3), and a globular carboxy-terminal domain (CTD), 
which  harbors  a  signature  cullin  homology  domain 
(CH),  a  highly  conserved  stretch  of  about  200  amino 
acids (Figure 2).
The cullin CTD binds to its RING partner, Regulator of 
cullins 1 (ROC1) or ROC2 (also called RING box protein 
(Rbx)1  and  Rbx2,  respectively),  which  recruits  the 
ubiquitin-loaded  E2  enzymes  for  catalysis.  The  CUL1-
ROC1  association  is  established  by  multiple  interface 
interactions, primarily involving CUL1’s α/β domain and 
the amino-terminal S1 β-strand of ROC1, which enable 
the formation of an intermolecular α/β hydrophobic core 
that essentially renders CUL1-ROC1 physically insepar-
able [6]. The cullin-RING interaction creates a catalytic 
core and is the most characteristic structural feature that 
defines CRLs [7].
On the basis of structural studies of the human S-phase 
kinase-associated  protein  1  (Skp1)-CUL1-F-box  (SCF) 
complex  [6]  and  the  CUL4A  RING  (CRL4A)  complex 
[8,9],  cullins  organize  CRLs  by  forming  two  distinct 
modules:  a  substrate-targeting  unit,  composed  of  a 
substrate-recognition protein and an adaptor protein that 
links the module to the cullin, and the RING component 
that is active in recruiting an E2 ubiquitin-conjugating 
enzyme (Figure 4). For instance, SCF contains a substrate 
recognition subunit known as the F-box protein, which is 
characterized by a 40-amino-acid F-box domain [10]. The 
Skp1  adaptor  protein  mediates  binding  of  the  F-box 
Box 1. The ubiquitin-proteasome system
The ubiquitin-proteasome system is a selective protein 
degradation pathway in which a substrate is first tagged with 
a chain of ubiquitin and the resulting modified protein is then 
recognized by the 26S proteasome, where proteolysis of the 
substrate takes place. The process of ubiquitination involves 
a three-tiered enzymatic cascade. First, the chemically inert 
ubiquitin molecule is activated in an ATP-dependent reaction by 
forming a thioester bond between the carboxy-terminal carboxyl 
group of ubiquitin and the catalytic cysteine of an E1 activating 
enzyme. Second, in a trans(thio)esterification reaction ubiquitin 
is transferred to the active site cysteine of an E2 ubiquitin-
conjugating enzyme. In the last step, an E3 ubiquitin ligase 
functions to orchestrate the transfer of ubiquitin to a substrate 
protein, forming an isopeptide bond between the ubiquitin 
carboxy-terminal glycine residue and substrate lysine ε-amino 
group. The action of an E3 typically involves recognition of a 
specific degradation motif (degron) on the substrate. The human 
genome encodes two E1 activating enzymes, 37 E2 conjugating 
enzymes and more than 500 E3 ubiquitin ligases [54]. A 
substrate protein can be conjugated with just one ubiquitin 
(monoubiquitination), one ubiquitin molecule at different lysines 
residues (multiubiquitination) or by a chain of several ubiquitin 
moieties (polyubiquitination). Ubiquitin contains seven lysine 
residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48 and Lys63) 
that can act as acceptors and result in entirely different chain 
conformations. Polyubiquitination has multifaceted outcomes 
that depend on the respective chain structure [54]. For instance, 
although Lys48-linked chains are the canonical recognition 
motif for the proteasome, Lys63-linked chains have important 
non-degradative roles in cell signaling, DNA-damage response 
and endocytosis [55]. Monoubiquitination typically has non-
proteolytic functions, such as the internalization of cell-surface 
receptors [56].
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Page 2 of 12protein to the amino terminus of CUL1. In CRL4A, the 
substrate-targeting unit is composed of damage-specific 
DNA binding protein 1 (DDB1) as the adaptor protein, 
and a member of the DDB1 and CUL4 associated factor 
(DCAF)  family  that  recognizes  a  substrate.  However, 
CRL3  does  not  contain  a  separate  adaptor  subunit. 
Instead,  it  incorporates  BTB  (Bric-a-brac,  Tramtrack, 
Broad-complex),  a  dual  function  molecule  capable  of 
binding  to  CUL3  and  targeting  a  substrate  (Figure  4). 
(SCF, also called CRL1, is historically the prototype of all 
CRLs and thus the name SCF remains commonly used in 
the current literature.)
Accumulating  evidence  points  to  a  common 
mechanism by which CUL1 to CUL5 build a substrate-
targeting  unit.  CUL1  to  CUL5  use  amino-terminal 
helices  H2  and  H5  of  CR1  to  anchor  their  cognate 
adaptors. There are two distinct types of recognition fold 
in the adaptor (Table 2). In the SCF, CRL2, CRL3 and 
CRL5 E3s, different adaptors (Skp1, Elongin C (EloC) or 
BTB) share a similar structural motif termed the Skp1/
Table 1. Chromosomal localization of the cullin genes from several representative species
	 	 	 	 	 	 	 	 Gene
	 	 Cul1	 Cul2	 Cul3	 Cul3a	 Cul3b	 Cul4	 Cul4a	 Cul4b	 Cul5	 Cul6	 Cul7	 Cul8	 Parc
Human 
  Gene ID  8454  8453  8452  NP  NP  NP  8451  8450  8065  NP  9820  NP  23113
  Chromosomal localization  7q36.1  10p11.21  2q36.2  NP  NP  NP  13q34  Xq23  11q22-q23  NP  6p21.1  NP  6p21.1
  Introns  21  20  15  NP  NP  NP  19  19/21  18  NP  25  NP  40
  Isoforms  1  1  1  NP  NP  NP  2  2  1  NP  2  NP  1
Mouse
  Gene ID  26965  71745  26554  NP  NP  NP  99375  72584  75717  NP  66515  NP  78309
  Chromosomal localization  6; B3  18; A1  1; C4  NP  NP  NP  8; A1.1  X; A2  9; C  NP  17; C  NP  17; C
  Introns  21  20  15  NP  NP  NP  19  22  18/19  NP  25  NP  41
  Isoforms  1  1  1  NP  NP  NP  1  1  2  NP  1  NP  1
Rat
  Gene ID  362356  361258  301555  NP  NP  NP  361181  302502  64624  NP  363191  NP  316228
  Chromosomal localization  4q24  17q12.1  9q34  NP  NP  NP  16q12.5  Xq11  8q24  NP  9q12  NP  9q12
C.	elegans
  Gene ID  176466  176806  178547  NP  NP  174198  NP  NP  179413  178214  NP  NP  NP
  Chromosomal localization  III  III  V  NP  NP  II  NP  NP  V  IV  NP  NP  NP
Drosophila
  Gene ID  (lin19)   35420  34896  NP  NP  35780  NP  NP  43434  NP  NP  NP  NP 
    35742
  Chromosomal localization  2R;   2L;   2L;   NP  NP  2R;   NP  NP  3R;   NP  NP  NP  NP
    43F1-  39E3-  35C5-      44A4-      98F6-         
    43F2  39E6  35C5      44A4      98F6       
A.	thaliana
  Gene ID  (ATCUL1)  839415  NP  (ATCUL3)  843303  834663  NP  NP  NP  NP  NP  NP  NP 
    825648      839226       
  Chromosomal localization  4  1  NP  1  1  5  NP  NP  NP  NP  NP  NP  NP
S.	cerevisiae
  Gene ID  (Cdc53)   NP  852886  NP  NP  NP  NP  NP  NP  NP  NP  (RTT101)   NP 
    851424                      853400
  Chromosomal localization  V  NP  VII  NP  NP  NP  NP  NP  NP  NP  NP  X  NP
S.	pombe
  Gene ID  2542393  NP  2542637  NP  NP  (pcu4)   NP  NP  NP  NP  NP  NP  NP 
              2543116
  Chromosomal localization  I  NP  I  NP  NP  I  NP  NP  NP  NP  NP  NP  NP
Gene IDs are as listed in Entrez Gene [59]. The intron number and transcript information are indicated for the cullin genes in human and mouse. Only the variants in 
Entrez Gene are indicated and other variants may exist. NP, not present.
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Page 3 of 12BTB/Pox  virus  and  zinc  finger  (POZ)  fold,  which  is  a 
primary  determinant  for  affinity  interactions  with  the 
cullin amino terminus. By contrast, the DDB1 adaptor of 
CRL4 lacks the Skp1/BTB/POZ fold and instead uses its 
BPB  domain  to  interact  with  the  CUL4A  H2  and  H5 
helices, as well as the amino-terminal extension [9]. In 
this  regard,  it  is  worth  commenting  on  the  enormous 
structural complexity of DDB1, a 127 kDa protein con-
tain  ing three large propeller folds [8], which potentially 
enable  multiple  interactions  with  cellular  proteins. 
Indeed,  DDB1  was  found  to  form  a  complex  with  de-
etiolated 1 (DET1), DDB1 associated 1 (DDA1) and the 
E2  ubiquitin-conjugating  enzyme  UBE2E  [11].  Initial 
efforts  to  isolate  the  human  CUL4A-containing  com-
plexes resulted in very large complexes that contained the 
constitutive photomorphogenesis 9 (COP9) signalosome 
[12].  It  remains  to  be  determined  whether  DDB1 
enhances the association between CRL4 and COP9. The 
role of the COP9 signalosome in CRL function is dis-
cussed in the next section.
Structural  and  biochemical  analyses  have  revealed 
additional protein-protein interactions that contribute to 
the  cullin-mediated  CRL  assembly.  In  addition  to  the 
Skp1-CUL1 interactions, Skp2’s F-box domain also binds 
to CUL1, thus contributing to the assembly of the SCFSkp2 
complex  [6].  Although  CUL3  mediates  interactions  to 
BTB proteins through the Skp1/BTB/POZ fold, it binds 
to a conserved helical structure carboxy-terminal of the 
BTB domain, which was named ‘3-box’ for CUL3-inter-
acting box [13] (Table 2). The CUL3-3-box association 
strengthens the CUL3-BTB protein interactions. Despite 
sharing the identical adaptor protein Elongin C (EloC), 
CUL2  and  CUL5  direct  the  assembly  of  distinct  E3 
complexes:  CRL2  with  von  Hippel-Lindau  (VHL)  or 
related  BC  box  proteins,  and  CRL5  containing  sup-
pressors  of  cytokine  signaling  (SOCS)-box  proteins 
Figure	1.	Phylogenetic	tree	of	the	cullin	gene	family. Phylogenetic tree based on the alignment of cullins of Homo sapiens (Hs), Mus musculus 
(Mm), Rattus norvegicus (Rn), Drosophila melanogaster (Dm) and Caenorhabditis elegans (Ce). Gene IDs are as listed in Table 1. ClustalX was used to 
align sequences using the standard settings. The tree was drawn using Figtree v1.3.1. The bar indicates the proportion of amino acid sites at which 
two compared sequences are different. Iso, isoform.
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Page 4 of 12(Figure  4).  However,  it  is  unclear  whether  CUL2  and 
CUL5 recognize specific determinants within VHL and 
SOCS-box proteins, respectively [14,15]. A recent study 
provided some insight into how CUL5 assembles into a 
CRL5 complex with the HIV protein Virion infectivity 
factor (Vif; a SOCS-box protein), thereby yielding an E3 
ligase  that  targets  the  human  antiviral  protein 
APOBEC3G for proteasomal degradation [16]. It seems 
that loops 2 and 5 of CUL5 are engaged in interactions 
with  Vif’s  SOCS-box  and  zinc  finger  motif  (H-(X)5-C-
(X)17-18-C-(X)3-5-H), respectively.
In summary, it seems that to assemble CRLs, cullins 
not  only  bind  to  a  common  recognition  fold  in  the 
adaptor, such as the Skp1/BTB/POZ motif (Table 2), but 
also form interface interactions with structural deter  mi-
nants within the substrate-recognition molecules (SRMs) 
that  include  F-box,  BTB,  VHL  and  SOCS  proteins. 
However,  future  structural  and  biochemical  studies, 
using  a  larger  set  of  substrates,  are  required  to  more 
rigorously define the ‘SRM determinants’. To understand 
the differential ability of CUL2 and CUL5 to assemble 
CRL2 and CRL5, respectively, it is critical to solve their 
structures, especially the amino terminus.
There are no structures available that reveal the three-
dimensional  organization  of  either  CUL7  or  PARC. 
Although  CUL7  resembles  CUL1  in  using  the  Skp1 
adaptor [17], it remains to be determined how CUL7 selects 
F-box  and  WD-repeat-domain-containing  protein  8 
(Fbw8).  At  present,  it  is  also  unclear  whether  PARC 
forms a multi-subunit complex.
Localization and function
Cullin family proteins are involved in a diverse array of 
functions, including cell-cycle control, DNA replication 
Figure	2.	Cullin	protein	domain	organization	in	humans. Cullin repeat 1 (CR1) anchors the cognate adaptor proteins, and the cullin homology 
domain (CH) at the carboxyl terminus is critical for binding of the RING-finger protein. The red line indicates the position of the neddylation site. 
For CUL7 and PARC the neddylation site is based on consensus sequence alignment without experimental verification. Size and location of the 
individual domains are schematic representations and do not depict the exact proportions. Abbreviations: aa, amino acids; CH, cullin homology 
domain; CPH, conserved domain in CUL7, PARC and HERC2; CR, cullin repeat; DOC, a domain similar to the DOC1 domain of the anaphase-
promoting complex/cyclosome but of unknown function; IBR, in between RING; RING, really interesting new gene.
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Box 2. E3 ubiquitin ligases
E3 ubiquitin ligases are a diverse group of enzymes that 
recognize both a substrate protein and an E2 ubiquitin-
conjugating enzyme. E3 ubiquitin ligases can be subdivided into 
two major classes [57]: HECT-type and RING-type E3 ligases.
The single-molecule HECT-type E3 ligases are characterized by a 
Homologous to the E6-AP carboxyl terminus (HECT) domain that 
forms a thioester intermediate with ubiquitin as a prerequisite for 
ubiquitin transfer to the substrate protein.
In contrast, RING-type E3 ligases use RING (really interesting new 
gene)-zinc finger domains to recruit and allosterically activate an 
ubiquitin-charged E2 enzyme for direct ubiquitin transfer to the 
substrate. RING finger domains have a characteristic architecture 
of three β strands, one α-helical domain and two free loops that 
are arranged by Zn2+ ions. The loops are stabilized by a cluster of 
cysteine residues and up to two histidines [57]. U-box E3 ligases 
are a subgroup of the RING-type E3s and contain a structurally 
modified RING-motif (the U-box) that lacks the ability to chelate 
Zn2+ ions [58].
Of about 300 RING proteins expressed in human cells, the multi-
subunit cullin-RING Ligase (CRL) complexes constitute the major 
group and are characterized by two signature components: a 
cullin (CUL) scaffold protein and the RING-finger protein ROC1 or 
ROC2 (also known as Rbx1/Hrt1 or Rbx2, respectively) [7].
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the cullin family proteins have been revealed by genetic 
ablation  experiments  in  a  variety  of  metazoan  model 
organisms, including mouse, C. elegans and Drosophila 
(Table 3). In Arabidopsis, CRLs regulate hormonal signal-
ing,  light  responses,  circadian  rhythms  and  photo-
morpho  genesis (for a recent review, see [18]). The cullin 
family proteins seem to be widely expressed and to locate 
both  to  the  nucleus  and  cytoplasm,  but  there  are  no 
compelling  data  suggesting  that  cullin  activity  is 
con  trolled  by  subcellular  localization  or  by  differential 
expression in a tissue-specific manner.
Cul1  and  Cul3  mouse  knockout  experiments  have 
revealed their indispensable roles in cell cycle progression 
and early embryogenesis (Table 3). The role of CUL1 in 
cell cycle control is understood in considerable detail. It 
was the pioneering work using the budding and fission 
yeast  systems  that  led  to  the  discovery  of  cullins  and 
other CRL components and their role in cell cycle control 
(reviewed in [19]). Work in C. elegans and Drosophila has 
Figure	3.	The	ubiquitin-proteasome	system. The conserved 76-amino-acid polypeptide ubiquitin (Ub) is activated in an ATP-dependent reaction 
by an E1 ubiquitin-activating enzyme and transferred to an E2 ubiquitin-conjugating enzyme. An E3 ubiquitin ligase binds both the substrate 
protein and a ubiquitin-charged E2 enzyme for ubiquitin transfer, resulting in the mono-, multi- (not shown) or polyubiquitination of the substrate. 
The mode of ubiquitination determines whether the substrate protein is degraded by the 26S proteasome or altered in a non-proteolytic manner. 
See Boxes 1 and 2 for additional information.
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Table 2. Cullin structures and cullin-RING E3 complex assembly
	 E3	components
	 	 Substrate	 	 	 Key	recognition	 Key	determinants	on	
Protein	 Adaptor	 recognition	 RING	 Structures	solved*	 fold	on	adaptor	 cullin	NTD
CUL1  Skp1  F-box protein  ROC1/Rbx1  CUL1-Rbx1-Skp1-F boxSkp2  Skp1/BTB/POZ fold in  CUL1 H2 and H5 helices [6]
        [6]; Skp1-Skp2 [60]  Skp1 [6] 
CUL2  EloC/EloB  VHL  ROC1/Rbx1  No CUL2 structure;   Skp1/BTB/POZ fold in  CUL2 H2 and H5 helices 
        VHL-EloC-EloB [60]  EloC [6,61]  [14]
CUL3  BTB (adaptor-  BTB (adaptor-  ROC1/Rbx1  SPOP BTB-SBC [13]  BTB [13]; 3-box [13]  CUL3 H2 and H5 helices 
  targeting)  targeting)        [62]
CUL4A  DDB1  DCAF  ROC1/Rbx1  DDB1-CUL4A-ROC1 [9];   BPB in DDB1 [9]  CUL4A H2 and H5 helices 
        DDB1-V protein [8]    [9]; CUL4A amino-terminal  
            extension [9]
CUL4B  DDB1  DCAF  ROC1/Rbx1  Not available  BPB in DDB1 (predicted)  CUL4B H2/H5 (predicted)
CUL5  EloC/EloB  SOCS protein  ROC2/Rbx2  CUL5CTD-Rbx1 [37];   Skp1/BTB/POZ fold in  CUL5 H2 and H5 helices
        SOCS2- EloC-EloB [63];   EloC [6,61]  [64]; CUL5 loop 2 (amino 
        HIV Vif-EloC-EloB [16]    acids 51 to 60) [16]; CUL5  
            loop 5 (amino acids 118 to  
            134) [16]
CUL7  Skp1   Fbw8  ROC1/Rbx1  CUL7 CPH-p53 TD [65]  Skp1/BTB/POZ fold in   Unknown 
          Skp1 (predicted)
PARC  Unknown  Unknown  Unknown  Not available  Unknown  Unknown
*Crystal structures of CRL complexes were solved with recombinant human proteins.
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Page 6 of 12demonstrated  the  requirement  of  CUL1  for  cell  cycle 
progression (Table 3). Mechanistically, it is believed that 
the CUL1-based SCF regulates the mammalian cell cycle, 
at least in part, by using the Skp2 F-box protein, which 
directs the ubiquitin-dependent degradation of p27 and 
p21  (inhibitors  of  cyclin-dependent  kinases),  thereby 
activating cyclin-dependent kinases [20]. SCF malfunc-
tion has been linked to malignancy, as mutations in the 
Fbw7 F-box protein are frequently found in a variety of 
human cancers [21].
Studies  with  Cul4  deletion  in  C.  elegans  have  estab-
lished  a  crucial  role  for  CUL4  in  DNA  replication 
(Table 3). It is well accepted that the CRL4 complex with 
the  DCAF  protein  Cdt2  as  substrate-recognition 
molecule (referred to as CRL4Cdt2) targets the replication 
initiation factor Cdt1 for degradation, thereby preventing 
DNA  re-replication  [22].  In  mammals,  CUL4A  and 
CUL4B  are  believed  to  be  functionally  redundant,  as 
deletion of Cul4a in mice resulted in viable animals and 
relatively subtle phenotypes (Table 3). Clearly, complete 
understanding of the physiological functions of Cul4 in 
mouse development requires future studies with animals 
lacking Cul4b and Cul4a/Cul4b.
There have been no mouse models for either Cul2 or 
Cul5. However, CRL2pVHL has a critical role in control of 
oxygen homeostasis, acting by targeting the α subunit of 
hypoxia-inducing transcription factor (HIF) for degrada-
tion (reviewed in [23]). Tissue-specific gene targeting of 
VHL in mice has demonstrated that efficient execution 
of CRL2pVHL-mediated HIF-1α proteolysis under normal 
levels of oxygen is fundamentally impor  tant for survival, 
proliferation,  differentiation  and  normal  physiology  of 
many cell types (reviewed in [23]). These studies have 
explained the tumor suppressor function of VHL, whose 
germline  mutations  inactivate  its  ability  to  form  the 
CRL2  complex  or  bind  to  HIF-α,  leading  to  the 
formation of highly vascularized tumors such as renal 
clear-cell carcinomas.
Figure	4.	Modularity	of	cullin-RING	E3	ligases. Cullin proteins are molecular scaffolds that assemble multi-subunit cullin-RING E3 ubiquitin 
ligase (CRL) complexes. The mammalian cullin protein family comprises eight members (CUL1 to CUL7 and PARC). In CRL, a cullin protein tethers 
both a substrate-recognition subunit, often through an adaptor protein, and the RING finger component. The cullin-organized CRL thus positions 
a substrate in close proximity to the RING-bound E2 ubiquitin-conjugating enzyme (not shown), which catalyzes the transfer of ubiquitin to the 
substrate. (a) General CRL composition. (b) Specific composition of the CRLs 1 to 7 and PARC. BTB, Bric-a-brac, Tramtrack, Broad-complex domain; 
DCAF, DDB1-CUL4 associated factor; DDB1, DNA damage-binding protein 1; Fbw8, F-box and WD repeat domain containing protein 8; PARC, 
p53-associated parkin-like cytoplasmic protein; SOCS, Suppressors of cytokine signaling; Skp1, S-phase kinase-associated protein 1; VHL-Box, 
von Hippel-Lindau box.
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Page 7 of 12Two  hereditary  human  diseases  have  been  linked  to 
genes  encoding  members  of  the  cullin  protein  family. 
Mutations  in  the  CUL7  gene  were  linked  to  3-M  syn-
drome (Online Mendelian Inheritance in Man (OMIM) 
ID 273750), an autosomal-recessive disorder character-
ized  by  pre-  and  postnatal  growth  retardation  (final 
height 3 to 4 standard deviations below the mean for the 
population),  facial  dysmorphism,  large  head  circum-
ference, normal intelligence, and skeletal anomalies that 
include  long  slender  tubular  bones  and  tall  vertebral 
bodies [24,25]. Huber et al. [24,25] identified CUL7 gene 
mutations in 52 out of 62 cases (84%), arguing for CUL7 
as  the  major  disease  gene  of  3-M  syndrome.  The 
mutations were located throughout the CUL7 gene and 
most  are  predicted  to  cause  premature  termination  of 
translation.  Reverse  transcriptase  (RT)-PCR  analysis  of 
patient  fibroblast  mRNA  detected  a  CUL7-specific 
transcript,  but  at  reduced  levels,  arguing  that  CUL7 
mRNA is expressed at least in a subset of 3-M syndrome 
patients. Approximately 50% of the mutations identified 
by  Huber  et  al.  [24,25]  are  located  within  the  cullin 
homo  logy domain (exons 19 to 24), which is responsible 
for ROC1 binding. Biochemical characterization of the 
CUL7  nonsense  and  missense  mutations  Arg1445X 
(where X indicates a stop codon) and His1464Pro, respec-
tively, were shown to render CUL7 deficient in recruiting 
ROC1. Arg1445X was predicted to yield a truncated CUL7 
polypeptide  (lacking  the  254  carboxy-terminal  amino 
acids),  and  His1464Pro  was  predicted  to  introduce  a 
structural alteration in the cullin homology domain [24].
A study by Maksimova et al. [26] identified 43 patients 
from 37 Yakut families, a geographically isolated ethnic 
group in Russia, with a short stature syndrome similar to 
3-M syndrome. A common mutation in the CUL7 gene, 
insertion T at position 4582 in exon 25, was identified 
that is predicted to cause a frameshift and subsequent 
premature stop codon at position 1553 (Q1553X).
Given that cyclin D1 [27] and insulin receptor substrate 
1  (IRS-1)  [28]  are  potential  proteolytic  targets  of  the 
CUL7 E3 ligase, it is tempting to speculate that either 
disturbed cyclin D1-dependent mechanisms or dysregu-
lated  IRS-1-mediated  signaling  pathways  might  contri-
bute to the pathomechanism of 3-M syndrome. Altogether, 
studies  with  3-M  and  Yakut  patients,  combined  with 
proliferative  defects  observed  in  Cul7  knockout  mice 
(Table 3), have strongly suggested a prominent role for 
CUL7 in growth regulation (reviewed by [29]).
Several  familial  mutations  in  the  CUL4B  gene  were 
associated  with  X-linked  mental  retardation  syndrome 
(XLMR; OMIM 300639) [30]. The authors [30] reported 
three  truncating,  two  splice-site  and  three  missense 
variants at conserved amino acids in the CUL4B gene on 
Xq24  in  8  of  250  families  (3%)  with  XLMR.  During 
adolescence of these patients a syndrome emerged with 
Table 3. Major physiological roles of cullins revealed by deletion studies with model organisms
Protein	 Mouse	 C.	elegans	 Drosophila
CUL1  Cell cycle and embryogenesis [66,67], with KO phenotypes,   Cell cycle [1]; germline  Cell cycle [70,71]; apoptosis [72];  
  including: embryonic lethality E5.5 to E6.5; accumulation of   apoptosis [68]; sex  eye development [73] 
  cyclin E; increased apoptosis in the ectoderm; large trophoblast   determination [69]   
  giant cells in blastocytes
CUL2  No mouse model  G1-to-S transition [74];  
    mitosis [74,75]; germline  
    lineage [76]; meiosis [77-79];  
    polarity [77-79]; oogenesis [80];  
    MPK1 activation [80]; hypoxic  
    response, aging [81,82] 
CUL3  Cell cycle and embryogenesis [83], with KO phenotypes including   Meiosis/mitosis transition [84];   Eye development [72]; sensory organ 
  embryonic lethality <E7.5; accumulation of cyclin E; impaired   mitosis [85]; meiosis [86]  [87]; neurons [88]; hedgehog signaling 
  S-phase entry; failure to endocycle in trophoblasts    [89,90]; actin cytoskeleton and cell  
      movement [91,92]
CUL4  Deletion of Cul4a alone yields no major defects in development   DNA replication [22]  Cell cycle [94]; DNA damage response
  as mice lacking Cul4a exons 17 to 19 are viable and normal [93],     [95]
  and mice lacking Cul4a exons 4 to 8 are viable, showing mild 
  decrease in mouse embryonic fibroblast proliferation [33]; a role  
  in DNA repair as skin-specific CUL4A KO show increased  
  resistance to UV-induced skin carcinogenesis [93]
CUL5  No mouse model  Oogenesis [80]; MPK1   Cell fate specification [96]; synapse 
    activation [80]  formation [96]; oogenesis [97]
CUL7  Embryonic development, as KO showed neonatal death [98];  
  required for growth in embryo and placenta [98]; formation of  
  vascular structure [98]
PARC  Not essential for development, as KO is viable and normal [99]
E, embryonic day; KO, knockout.
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Page 8 of 12delayed puberty, hypogonadism, growth retardation, foot 
abnormalities,  relative  macrocephaly,  central  obesity, 
aggressive outbursts and seizures. The complex pheno-
type  of  patients  with  CUL4B  mutations  argues  for 
pleiotropic roles of CUL4B that remain to be determined.
The cullin-based CRLs function through their cognate 
substrate-recognition  molecules,  such  as  the  F-box, 
SOCS, BTB and DCAF proteins (Figure 4 and Table 2). 
The F-box, SOCS, BTB and DCAF protein families each 
contain a distinct motif that is recognized by an adaptor 
molecule, which is linked to a cognate cullin (Figure 4). 
For example, humans contain about 61 F-box proteins, 
all of which can bind to Skp1 through the F-box domain. 
Through Skp1, which binds to CUL1 (Table 2), most of 
the F-box proteins can thus be assembled into the SCF 
E3  complex  (Figure  4).  Bioinformatics  studies  have 
identified hundreds of human genes that are predicted to 
encode F-box, SOCS, BTB and DCAF proteins, thereby 
potentially forming over 200 CRLs (Figure 5). Although 
the  extent  of  the  CRL  family  requires  experimental 
verification, it is nonetheless reasonable to assume that 
CRLs  target  numerous  cellular  protein  substrates  and 
hence  have  an  impact  on  all  biological  processes.  In 
addition, studies with F-box proteins, including β-TrCP, 
Skp2 and Fbw7, demonstrate an ability of one substrate 
recognition protein to bind multiple substrates, thereby 
expanding  the  functional  range  of  CRLs.  For  recent 
reviews  on  the  diverse  targeting  functions  of  these 
proteins,  see  [10,31]  (F-box  family),  [32]  (BTB  family) 
and [33,34] (DCAF family).
Most, if not all, cullins are found covalently conjugated 
with an ubiquitin-like molecule, Nedd8. This modification, 
termed neddylation, activates the E3 ligase activity of CRLs 
by  promoting  substrate  polyubiquiti  na  tion  (reviewed  by 
[35]). Recent studies have suggested conformation-based 
mechanisms that explain the acti  vat  ing role of neddylation. 
In vitro mutagenesis experi  ments have suggested that the 
interactions between human ROC1 and CUL1’s carboxy-
terminal tail in the un  modified state render SCF inactive 
[36]. It was proposed that the conjugation of Nedd8 to the 
residue  K720  of  CUL1  induces  drastic  conformational 
changes in CUL1 that liberate ROC1, thereby driving SCF 
into  an  active  state.  This  hypothesis  was  supported  by 
recent structural studies by Schulman and colleagues [37] 
that revealed extensive conformational changes in CUL5 
when conjugated with Nedd8. Another activating mecha-
nism, proposed by Schulman and colleagues [37], suggests 
that the neddylation-mediated conformational changes in 
cullin  enabled  the  repositioning  of  the  RING-tethered 
ubiquitin-loaded E2 to a bound substrate for catalysis. In 
support of this model, in vitro cross-linking experiments 
have revealed that neddylation brought a SCF substrate 
into  a  close  proximity  to  an  E2  ubiquitin-conjugating 
enzyme [38].
Neddylation  is  reversed  by  the  COP9  signalosome, 
which  enzymatically  removes  Nedd8  from  a  cullin 
molecule  [39].  COP9  is  an  eight-subunit  complex  that 
was originally identified as a suppressor of plant photo-
morphogenesis [40]. It was shown that COP9’s Jab1/Csn5 
subunit  contains  a  Jab1/MPN  domain  metalloenzyme 
(JAMM)  motif  critical  for  COP9’s  Nedd8  isopeptidase 
activity [39]. It is thus believed that CRL activities are 
dynamically  controlled  by  cullin  neddylation-deneddy-
lation cycles. It was observed that an SCF complex bound 
to  a  substrate  contained  higher  levels  of  neddylated 
CUL1,  suggesting  that  substrate-E3  interactions  may 
trigger neddylation [41]. The detailed mechanism, how-
ever, remains elusive.
CRL  is  also  regulated  by  Cullin-associated  and 
neddylation-dissociated-1 (CAND1), which inhibits the 
E3 ligase activity of CRLs by binding to all cullins in their 
un-neddylated  forms  [42,43].  The  CUL1-CAND1 
interaction is understood at the structural level, as the 
human  CUL1-Rbx1-CAND1  complex  showed  that 
CAND1  binds  both  the  CUL1  amino  and  carboxyl 
termini [44]. However, a recent study [45] has revealed 
that only a small fraction of cullin is bound to CAND1 in 
Figure	5.	Cullins	assemble	the	largest	subfamily	of	E3	ubiquitin	
ligases. Pie chart of the numbers of human E3 ubiquitin ligases, 
estimated from the numerical distribution of genes predicted to 
encode E3 RING or HECT polypeptides or, in the case of CRLs, the 
substrate-recognition molecules that include F-box, SOCS, BTB with 
3-box and DCAF proteins. Numbers refer to human gene numbers 
for F-box, SOCS, HECT, U-box and non-CRL RING proteins, derived 
from Li et al. [53]. The estimation for the human DCAF family is 
described by Lee and Zhou [34]. Kay Hofmann has kindly provided 
the tally of human genes encoding BTB and 3-box proteins (personal 
communication). The Hofmann estimation is based on the structural 
work from Schulman and colleagues [13], which identified a critical 
role for the 3-box in the assembly of CRL3 with the SPOP BTB protein. 
72 BTB-only (without 3-box) genes have not been counted for the 
estimation of CRL3s.
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Page 9 of 12human cells. Future studies are required to determine the 
precise role of CAND1 in regulating CRLs.
Frontiers
By  organizing  CRLs  that  presumably  direct  numerous 
substrates to ubiquitin-dependent degradation, the cullin 
family  proteins  build  a  cellular  regulatory  network  of 
fundamental importance in controlling protein homeo-
stasis, thereby altering a wide range of biological processes, 
from cell cycle regulation to signal trans  duction.
However, there are several areas that need attention. 
The  development  of  cutting  edge  technology  for  the 
identification of CRL substrates is crucial. Although bio-
informatics predicts a large number of CRLs (Figure 5), 
we still have knowledge on only a handful of substrates. 
Proteomics-based  approaches  and  newly  developed 
global  protein  stability  profiling  technology  [46]  have 
proven effective in the identification of novel substrates. 
However, it remains to be seen whether these methods, 
coupled with agents that affect cell signaling, could lead 
to the isolation of substrates, whose turnover rates are 
dictated  by  often  transient  post-translational  modifica-
tions, such as phosphorylation [10], prolyl hydroxylation 
[23] and glycosylation [47].
Although the assembly of a majority of CRLs is under-
stood in considerable detail (Table 2 and Figure 4), little 
is known about the control of the assembly in cells. It 
has  long  been  suggested  that  the  substrate-CRL 
interactions dictate the cullin neddylation-deneddylation 
cycle,  which  turns  on  and  off  the  CRL’s  E3  ubiquitin 
ligase activity. However, the mechanism by which this is 
achieved is elusive.
Given the intricate role of cullins and CRLs in a multi-
tude of biological processes, it is likely that cullin dys-
function will emerge as a pathogenetic factor in diseases. 
Indeed, CUL7 and CUL4B mutations have been identified 
in human disorders, but further studies are required to 
determine the underlying pathomechanisms.
Genetic studies in organisms from yeast to mouse have 
revealed a prominent role for cullins and CRLs in cell-
cycle progression (Table 3). Dysfunction of CRL activities 
has  been  associated  with  oncogenic  transformation 
(reviewed by [48]). Thus, targeting CRLs is an emerging 
frontier  in  rational  drug  design.  Recent  advances  have 
validated efforts in drug-targeting the ubiquitin-protea-
some system, with the proteasome inhibitor bortezomib 
now approved for the treatment of patients with multiple 
myeloma or mantle cell lymphoma (reviewed by [49]). A 
small  molecule  inhibitor  (MLN4924)  suppressing  the 
Nedd8 activating pathway is currently in clinical trials, 
having  demonstrated  success  in  tumor  suppression  in 
animal  model  studies  [50],  and  two  small  molecule 
inhibitors  have  been  identified  recently  to  inhibit  SCF 
activities by different mechanisms [51,52].
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